Novartis International AG http://www.novartis.com Novartis and collaborators discover novel antimalarial drug candidate 2010-09-03T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1442436.shtml Novartis International BioCamp provides forum for future research and business leaders to engage in scientific innovation 2010-08-30T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1441156.shtml Novartis drug Tasigna® approved in Switzerland after fast-track review for treatment of patients with newly diagnosed Ph+ CML 2010-08-27T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1440842.shtml Novartis receives FDA approval of Tekamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure 2010-08-27T07:00:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1440875.shtml Novartis completes 77% majority ownership of Alcon adding new growth platform in eye care to its leading healthcare portfolio 2010-08-26T07:00:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1440394.shtml Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research 2010-08-23T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1439402.shtml Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox®[1] 2010-07-23T17:22:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1433879.shtml Novartis receives approval in China for Rasilez, a first-in-class direct renin inhibitor for high blood pressure, the leading preventable cause of death in China 2010-07-20T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1432666.shtml Novartis delivers strong financial performance in second quarter, underpinned by increased momentum in innovation 2010-07-15T07:00:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1431809.shtml Plaintiffs and Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, agree to resolve all gender discrimination claims associated with class action 2010-07-14T23:00:00 CET http://www.novartis.com/newsroom/media-releases/en/2010/1431791.shtml